ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases, today announced that its executive management team will participate in BIO-...
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
* Development of Leptin receptor-based technology and hybrid LNP platform * Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential applications in CNS-targeted therapeutics * Technology validated by winning first place in...
ImmunoForge to Conduct Strategic Partnering at Bio-Europe Spring 2026
* Conducting global licensing partnering of LMT15, a proprietary BBB Shuttle platform * Also discussing global out-licensing of Phase 2 stage new drugs PF1801 and PF1804 SEOUL, South Korea, March 12, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd. , a biopharmaceutical company developing treatments...
ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
* Focusing on global out-licensing of Phase 2 assets PF1801 and PF1804. * Company to engage with global big pharma in San Francisco to accelerate U.S. clinical entry. SEOUL, South Korea, Jan. 1, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd. (Co-CEOs Sung-Min Ahn and Kiho Chang), a clinical-stage ...
ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS
SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ -- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for 'Pemziviptadil (development code name PF1804),' a treatment for DMD (Duchenne Muscular Dystrophy) cardiomyopathy, from the U.S. Food and Drug Administration...
UNLIMEAT Kimbap Products Now Available via DoorDash's DashMart
- UNLIMEAT is now being sold on DoorDash's DashMart, the company's online convenience store, to make UNLIMEAT Kimbap available nationwide. LOS ANGELES, May 30, 2024 /PRNewswire/ -- Frozen kimbap has become extremely popular lately – it's flying off the shelves and has become a new sensation in ...
UNLIMEAT Pulled Pork Wrap Now Available at All Starbucks Stores in HK
* Starting April 16th, Starbucks launched UNLIMEAT pulled pork wrap as its newest plant-based option. * UNLIMEAT's Starbucks collaboration is the most recent in a series of collaborations between UNLIMEAT and global companies inHong Kong like Seven Eleven, and Ikea. HONG KONG, April 22, 2024...
UNLIMEAT's Plant-Based Teriyaki Rice Bowls Now Served at Hong Kong's IKEA Stores
- UNLIMEAT Launches Alternative Meat Dish at IKEA Stores in Hong Kong to Celebrate Earth Month HONG KONG, April 21, 2022 /PRNewswire/ -- UNLIMEAT, the popular brand of plant-based meat, has announced that it is launching a dish incorporating its plant-based meat at all Hong Kong IKEA branches st...
UNLIMEAT Launches Alternative Meat Menu Items at Gyudon Chain Sukiya's China Restaurants
* Japan's leading Gyudon restaurant brand, Sukiya, launched UNLIMEAT Vegetable Gyudon in 15 of its branches inChina * Gyudon also began using UNLIMEAT meat alternatives for 4 new plant-based bulgogi menu items SEOUL, South Korea and SHANGHAI, Dec. 23, 2021 /PRNewswire/ --UNLIMEAT, Asia's lead...
Unlimeat Sandwich to Debut in Hong Kong 7-Eleven Stores
SEOUL, South Korea, Nov. 29, 2021 /PRNewswire/ -- Unlimeat, a leading alternative meat brand inAsia owned by Zikooin Company, rolled out its vegan meals across 800 7-Eleven locations inHong Kong. The vegan meat maker's newly launched "Unlimeat slice sandwich" is marinated using a barbecue sauce t...
Zikooin Company Raises USD 23 Million
* Funds raised from KDB Bank and new investors. * Plans to build one of Asia's largest plant-based meat factories in Jecheon city. SEOUL, South Korea, Nov. 23, 2021 /PRNewswire/ -- Zikooin Company, a plant-based meat substitute manufacturer (CEO Min, Keum-chae) attracted investments totaling ...
